Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome
Clinical trial NCT01552681 · TERMINATED
Trial details
- NCT number
- NCT01552681
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-01-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.